Molecular Templates, Inc. Reports Fourth Quarter 2022 Financial Results and Business Update Mar 30, 2023 6:10pm EDT
Molecular Templates Announces IND Acceptance by FDA for MT-8421 ETB Program Targeting CTLA-4 Mar 09, 2023 10:02am EST
Molecular Templates, Inc. to Present Interim Results on MT-5111 at the 45th Annual San Antonio Breast Cancer Symposium (SABCS) and Participate at the 64th American Society of Hematology (ASH) Annual Meeting Dec 02, 2022 5:02pm EST
Molecular Templates, Inc. to Present Fireside Chats at Two Upcoming Investor Conferences: Evercore ISI’s 5th Annual HealthCONx Conference and Piper Sandler’s 34th Annual Healthcare Conference Nov 23, 2022 4:30pm EST
Molecular Templates, Inc. to Present Interim Data and Host R&D Day at The Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting Nov 04, 2022 11:00am EDT
Molecular Templates’ Presentations at the 2022 ASCO Annual Meeting Demonstrate Advancement in PD-L1 and HER2 Programs Jun 06, 2022 8:00am EDT
